One month after Ang II treatment, Pdzrn3f/f mice showed an eccentric heart hypertrophy and severe contractile dysfunction, whereas MCM-Pdzrn3f/f mice maintained their LVEF at the same level as seen at earlier time points (Fig. 7h). Here, AGT is linked to cardiac hypertrophy.